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Abstract 
Tissue engineering of clinically applicable dermo-epidermal 
skin substitutes is crucially dependent on the three-dimensional 
extracellular matrix, supporting the biological function of 
epidermal and dermal cells. This matrix essentially determines the 
mechanical stability of these substitutes to allow for safe and 
convenient surgical handling. Collagen type I hydrogels yield 
excellent biological functionality but their mechanical weakness 
and their tendency to contract and degrade does not allow 
producing clinically applicable transplants of larger sizes. 
We show here that plastically compressed collagen type I 
hydrogels can be produced in clinically relevant sizes (7 x 7 cm), 
and can be safely and conveniently handled by the surgeon. Most 
importantly, these dermo-epidermal skin substitutes mature into a 
near normal skin that can successfully reconstitute full thickness 
skin defects in an animal model. 
Introduction 
A major challenge in plastic and reconstructive surgery is the 
reconstitution of large, full thickness skin defects. In this case both, 
epidermis and dermis have to be regenerated in a concerted fashion. (1-
3).  
Almost perfect closure of full thickness wounds can be achieved by 
the transplantation of healthy, autologous, full thickness skin. However, 
only relatively small areas (less than 2% of the body surface) can be 
Page 2 of 33 
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
C:
 M
et
ho
ds
M
od
ifi
ed
 p
la
sti
c 
co
m
pr
es
sio
n 
of
 c
ol
la
ge
n 
hy
dr
og
el
s p
ro
vi
de
s a
n 
id
ea
l m
at
rix
 fo
r c
lin
ic
al
ly
 a
pp
lic
ab
le
 sk
in
 su
bs
tit
ut
es
 (d
oi:
 10
.10
89
/te
n.T
EC
.20
11
.05
61
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
2 
 
covered by full thickness skin grafts, as the harvesting of these creates 
massive trauma at the donor sites. Allogenic full thickness skin (e.g. donor 
skin) can only be used as temporary wound coverage, as it will be 
immunologically rejected with time (4). A third option for the surgeon are 
autologous split thickness skin grafts, which consist of the complete 
epidermis and a thin dermal portion. The corresponding procedure is the 
current “gold standard” to treat third degree skin defects. As there is 
almost always a complete recovery of the donor sites, this method 
represents a reasonable solution and is therefore widely used (5). 
However, a drawback of this method is that, particularly for skin defects 
larger than 60% BSA, the availability of healthy split thickness skin is 
limiting (3, 5). 
Superior healing and good long term function of split thickness skin 
are largely dependent on a functional dermis. Thus, it is absolutely crucial 
in skin reconstitution to restore a high quality dermal compartment. 
Acellular dermal templates such as IntegraDRT®, used in combination with 
split thickness skin transplants, have brought about certain improvements 
regarding long-term functional and cosmetic results, but this treatment 
requires a two-step, staged procedure (6-8). 
We describe here the development of a clinically applicable, 
autologous full thickness skin substitute, explicitly including a functional 
dermal compartment. It is a centrally positive effect of the dermal 
fibroblasts that these essentially support the deposition of a basement 
membrane and the proliferation, differentiation and stratification of 
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epidermal keratinocytes (9-11). Most likely this is due to the permanent 
production of a set of biologically active growth factors that can act in 
physiological concentrations at their appropriate locations.  
Our previous work has provided evidence for the efficiency of collagen 
type I hydrogels in supporting the generation of organotypic epithelial 
structures and dermo-epidermal skin substitutes (12-16). The drawback 
of conventional collagen type I hydrogels is their mechanical instability, 
which does not allow the production of larger gel-based transplants.  
We report here a modified method to generate highly functional, 
mechanically stable skin substitutes, based on plastic compression (PC) of 
collagen type I hydrogels (17). Because of the significantly higher density 
of collagen fibres, gel contraction and degradation are dramatically 
reduced. Autologous human fibroblasts can be evenly distributed in the 
three dimensions of the hydrogel and can be plastically compressed 
without affecting their viability and biological function (17, 18). Notably, 
such skin substitutes can be prepared from small skin biopsies, and be 
successfully applied in one surgical intervention (19, 20).  
 
Material and Methods: 
Isolation and culture of human primary keratinocytes and 
fibroblasts 
Human skin samples from foreskins were obtained after permission 
by the ethic commission of the Canton Zurich, and after written informed 
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consent of the parents or patients. Skin biopsies were cut into small 
pieces of about 10 mm2 and digested for 15-18h at 4°C in 12 U/ml 
dispase in HBSS, containing 5 µg/ml gentamycin. The epidermis was 
mechanically separated from the dermis using forceps. Epidermal cells 
were isolated by incubation in 1% trypsin, 5 mM EDTA for maximal 3 min 
at 37°C, and then resuspended in serum-free keratinocyte medium (SFM) 
containing 25 µg/ml bovine pituitary extract, 0.2 ng/ml EGF, and 5 µg/ml 
gentamycin. Medium was changed every 2-3 days. Isolated cells were a 
mixture of mainly keratinocytes and melanocytes and were cultured in 
SFM. 
The dermal tissue was digested in 2 mg/ml collagenase 
(Clostridiopeptidase A) for approximately 60 min at 37°C. Isolated cells 
were seeded on 10 cm (diameter) cell culture dishes containing fibroblast 
growth medium (DMEM supplemented with 10% FCS, 4mM L-alanyl-L-
glutamine, 1 mM sodium pyruvate, and 5 µg/ml gentamycin) and allowed 
to attach overnight, before dead cells and erythrocytes were removed by 
3 washes in PBS. Collagenase was from Sigma (Buchs, Switzerland), all 
other compounds were from Invitrogen (Basel, Switzerland). 
Culture of dermo-epidermal skin substitutes 
Dermo-epidermal skin substitutes were prepared using a previously 
established transwell system (6 well cell culture inserts with membranes 
of 3.0 µm pore-size, BD Falcon, Basel, Switzerland). An acidic solution of 
bovine collagen type I (5 mg/ml, Symatese Biomatériaux, 69630 
Chaponost, France) (containing Neutral Red pH indicator) was neutralized 
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on ice by dropwise addition of 0.5 M NaOH and immediately mixed with 
5x104 human primary dermal fibroblasts (passage 1-2) suspended in 
DMEM. The total volume of the resulting gel was either 2 ml or 5ml. The 
fibroblast containing gels were cultured in DMEM for 7 days before 7.5x105 
keratinocytes were seeded on the surface of each gel. After initial 
submersed cultivation in Rheinwald and Green keratinocyte differentiation 
medium (21) (RGM: 3 parts DMEM and one part Ham’s F12, 10% FCS, 4 
mM L-glutamine, 1 mM sodium pyruvate, 5 µg/ml gentamycin (all 
Invitrogen, Basel, Switzerland), 0.4 µg/ml hydrocortisone, 5 µg/ml insulin, 
2 nM triiodothyronine and 180 µM adenine (all Sigma, Buchs, Switzerland)) 
for 7 days. Thereafter the cultures were shifted to the air-liquid interface. 
For that 1.2 ml of culture medium were added to the lower filter 
compartment, whereas the upper surface of the skin substitute was 
exposed to air for additional 10 days. Medium changes were performed 
every 2-3 days. 
Plastic compression of round collagen hydrogels (2.3 cm in 
diameter) 
T-shaped compression stamps (FIG. 1B, II) were constructed from 
polytetrafluoroethylene (PTFE) to fit into 6-well filter inserts (BD Falcon, 
Basel, Switzerland). The length of the cylindrical part was chosen to obtain 
0.5 or 1.0 mm thick compressed gels. For horizontal compression, a 
guiding bar was inserted into the compression stamp cylinder. 
Compression pressure and speed was adjusted using steel weight rings 
(FIG. 1B, I). Collagen gels containing 5x104 fibroblasts were prepared in 
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cell culture 6-well filter inserts as described above and incubated for 2 h at 
37°C prior to compression. The filter inserts were transferred on sterilized 
filter paper (Whatman, VWR International, Dietikon, CH) and the 
compression cylinder was inserted, loaded with 150 g weights and the 
gels were compressed to their final thickness during 5 min. The stamp 
was removed with the gel remaining in the filter insert. The insert, 
containing the compressed gel, was transferred into the 6-well dish after 
compression, and incubated in fresh fibroblast medium. Seven days after 
compression, keratinocytes were seeded on the gels according to the 
procedure described above. 
Quantification of gel volume loss 
To estimate the volume loss of collagen gels during cultivation in 
presence of fibroblasts, the wet weight of compressed and uncompressed 
gels was measured in a time course over 21 days after gel preparation. 
Collagen gels (5 ml) containing 5x104 human dermal fibroblasts were 
prepared and compressed to 0.5 mm as described above in 6-well cell 
culture inserts. Uncompressed control gels (2 ml) containing 5x104 human 
dermal fibroblasts were prepared as described previously (15). Before 
weighing, the medium was carefully aspirated from the gel and insert. The 
insert containing the gel was then weighed under sterile conditions, and 
then transferred back into fresh fibroblast growth medium. Gel wet weight 
was calculated by subtraction of empty insert weight. All weight 
measurements were performed on 3 gel replicates per condition and gel 
weight loss at different time points was determined.  
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Plastic compression of square collagen hydrogels (7 x 7 cm) 
To produce and compress square 7 x 7 cm collagen gels, we 
constructed a large compression chamber made from PTFE using a 
computerized numerical control (CNC) drilling machine (FIG. 4). A 0.5 
mm thick sterilized filter paper (Whatman, VWR International, Dietikon, 
Switzerland) was placed into the perforated base plate and covered by a 
PET track-etched membrane with 5.0 m pore size (Oxyphen AG, Lachen, 
Switzerland) (FIG. 4A and B, I). Then the casting frame (FIG. 4A and B, 
II) was clipped to the base plate to seal the chamber. 5x105 human 
primary dermal fibroblasts were diluted in 15 ml fibroblast growth medium, 
mixed well with 30 ml of bovine collagen Type I (5 mg/ml, Symatese 
Biomatériaux, Chaponost, France) and neutralised with 0.1 M NaOH on ice. 
The mixture was poured immediately into the chamber and incubated for 
10 min at RT, then for 2 h at 37°C. For compression, the stamp (FIG. 4A, 
III) was inserted into the guiding bars and weights were added. The final 
thickness of the compressed gels (0.6 mm) was determined by the stamp 
length. After 20 min of compression, the stamp was removed and the gel 
was transferred into a 150 mm2 cell culture flask with re-closable lid (TPP, 
Trasadingen, Switzerland) containing fibroblast growth medium. The 
compressed gels were incubated floating in fibroblast growth medium at 
37°C, 5% CO2. After initial cultivation for 7 days, 9x10
6 keratinocytes 
were seeded onto the gels and medium was switched to RGM. Medium 
was renewed every 1-2 days. Keratinocyte confluence, survival, and 
spreading was observed using fluorescein diacetate live cell staining.  
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Fluorescein diacetate live cell staining 
Fluorescein diacetate (FdA) staining was performed as published and 
proven to be suitable for the determination of cell viability in tissue-
engineered skin (22, 23). In short, cell culture medium was replaced for 2 
min with the equal volume of 5 M FdA in PBS, freshly prepared from a 
stock solution of 5 mM FdA in acetone. FdA was removed by washing 
twice in PBS before fresh culture medium was applied. Overview pictures 
of fluorescein fluorescence were taken using an imaging system with 
epiblue exitation and FITC emission filter (G:BOX, Syngene, Cambridge, 
UK). Detailed views were acquired using NIKON SMZ1500 fluorescent 
stereo microscope with FITC filters and NIKON DXM1200F camera.  
Transplantation of cultured dermo-epidermal skin substitutes 
Immuno-incompetent female nu/nu rats (8-10 weeks old, Harlan, 
Horst, Netherlands) were anesthetized with 15 mg/kg Ketamin (Ketalar®, 
Parke-Davis, Morris Plains, New Jersey, USA), anaesthetised by inhalation 
of 5% Isofluran® (Baxter, Volketswil, Switzerland) and maintained by 
inhalation of 2.5% Isofluran® via mask. For eye protection Viscotears® 
cream (Novartis, Bern, Switzerland) was applied. Round gel samples were 
cut with a punch, 26 mm in diameter, and transplanted onto full thickness 
skin defects created surgically on the back of the animals and encased by 
polypropylene rings, 26 mm in diameter (modified Fusenig chamber (24)). 
The transplants were covered with a silicon foil. After operation, 0.5 
mg/kg buprenorphine (Temgesic®, Essex, Luzern, Switzerland) was 
injected subcutaneously. The animals were sacrificed by CO2 application 
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21 days after transplantation. Grafts were excised in toto, embedded in 
O.C.T. compound (Tissue-Tek®, Sakura Finetek, Japan) and 12 m thick 
cryosections were prepared.  For histological analysis sections were 
stained with haematoxylin and eosin (Sigma, St. Louis, MO, USA) and 
thereafter mounted within Eukitt® (Fluka, Buchs, Switzerland). 
Antibodies 
Following primary antibodies were used for immunostaining: K1 
(clone LHK1, 1:200, Novus Biologicals, Littleton, CO, USA); K15 (clone 
LHK15, 1:100, R&D Systems ,Abingdon, UK); K19 (clone RCK108, 1:100, 
Santa Cruz, Labforce AG, Nunningen, Switzerland); Ki67 (clone B56, 
1:200, ABD Serotec, Dusseldorf, Germany); Laminin-332 (clone P3H9-2, 
1:100,  Chemicon, Millipore AG, Zug, Switzerland); human CD90/Thy-1 
(clone AS02, 1:100,  Calbiochem, VWR, Dietikon, Switzerland); CD31 
(clone TDL-3A12, 1:50, BD Pharmingen, Allschwil, Switzerland); 
melanosome (clone HMB45, 1:50, Dako, Baar, Switzerland); integrin 6-
PE (clone GoH3, 1:50, BD Pharmingen, Allschwil, Switzerland). Actin 
filaments were stained using Phalloidin-TRITC 0.1 M (Sigma, Buchs, 
Switzerland). 
For immunofluorescence, the primary antibodies were pre-incubated 
with Alexa 555 or Alexa 488 conjugated polyclonal goat F(ab’)2 fragments, 
according to the instructions of the manufacturer (Zenon Mouse IgG 
Labeling Kit, Molecular Probes, Invitrogen, Basel, Switzerland). 
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Immunofluorescence staining 
Cryosections (12 m) were fixed and permeabilized in acetone for 5 
min at -20°C, air dried and washed 3x in PBS. After blocking 30 min in 
2% BSA in PBS (Sigma, Buchs, Switzerland), the antibody mixtures were 
added in blocking buffer for 1 h at room temperature. Slides were washed 
for 5 min in PBS, nuclei stained for 5 min with 1 µg/ml Hoechst 33342 
(Sigma, Buchs, Switzerland) in PBS and then washed twice for 5 min in 
PBS. Finally, the samples were mounted with Dako fluorescence mounting 
solution (Dako, Baar, Switzerland). 
Fluorescence microscopy 
Fluorescence microscopy pictures were acquired using a DXM1200F 
digital camera connected to a Nikon Eclipse TE2000-U inverted microscope 
equipped with Hoechst, FITC, and TRITC filter sets or Nikon SMZ1500 
stereo microscope with FITC filters (Nikon AG, Egg, Switerland; Software: 
Nikon ACT-1 vers. 2.70)  
Images were processed with Photoshop 7.0 (Adobe Systems Inc, 
Munich, Germany). 
Electron Microscopy  
All electron microscopy procedures were performed at the Center for 
Microscopy and Image Analysis of the University Zurich, Switzerland, 
according to the center’s general protocols.  
Tissue samples for transmission electron microscopy were prefixed in 
0.1 M cacodylate buffer (Merck, Hohenbrunn, Germany), pH 7.3 
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containing 2.5% glutaraldehyde for 2 hours. After washing in cacodylate 
buffer, the samples were postfixed in 1% OsO4 and 1.5% K4Fe(CN)6 for 1 
hour, then dehydrated in a graded series of ethanol and embedded in 
EPON 812 (Catalys AG, Wallisellen, Switzerland). Approximately 50-70 nm 
ultra thin sections were transferred onto copper grids and contrasted with 
4% uranyl acetate and 3% lead citrate. The photographs were aquired 
using a CM 100 transmission electron microscope (Philips, Eindhoven, The 
Netherlands). Where not indicated differently, reagents were from Sigma 
(Buchs, Switzerland). 
For scanning electron microscopy (SEM), samples were fixed in 3% 
glutaraldehyde in PBS for 40 min, and then washed 3 times in PBS, 
followed by postfixation in 2% Osmiumtetroxid for about 20 min. After 3 
washes in destilled water, the samples were dehydrated in a graded series 
of ethanol, then washed 3 times in absolute ethanol and dried in a Critical-
Point-Dryer. The dried samples were glued on SEM stubs and coated with 
Platinium. Pictures were acquired using a Zeiss Supra 50 VP scanning 
electron microscope. All reagents were from Sigma (Buchs, Switzerland). 
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Results: 
Defined plastic compression improves mechanical properties of 
collagen gels  
The drawback of uncompressed collagen type I hydrogels is their 
mechanical instability (FIG 1A). We have now developed two different 
hydrogel compression devices, which allow plastic compression of collagen 
hydrogels, and hence the production of mechanically resistant, dermo-
epidermal skin substitutes to be used both, experimentally and clinically. 
One of the compression devices is compatible with commercially 
available 6-well cell culture membrane inserts (FIG. 1B). Its compression 
stamp was designed to stop compression at a defined thickness of 0.5 mm 
to create a real three-dimensional matrix rather than a collagen foil. 
Collagen gels (11 mm thick) were prepared in 6-well cell culture 
membrane inserts and compressed to 0.5 mm. Liquid drain flux through 
the membrane was sufficient to allow compression within 3 - 5 min when 
loaded with 150 g weights. The collagen type I concentration in 
compressed hydrogels was approximately 65 mg/ml. The resulting gels 
were mechanically stable with significantly improved handling properties 
in comparison to uncompressed gels (FIG. 1A, C).  
Electron Microscopy of plastically compressed collagen hydrogels  
Transmission electron microscopy (TEM) revealed that typical striated 
collagen fibres were detectable both in compressed and uncompressed 
gels (FIG. 2A and B). However, fibre concentration was significantly 
higher in compressed gels (FIG. 2B). Collagen fibres were more aligned 
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parallel in compressed gels (FIG. 2B). These observations are in line with 
previous reports on collagen fibre organisation in compressed gels (25). 
Scanning electron microscopy (SEM) revealed that compressed 
collagen gels contained several layers of parallel dense collagen layers 
that were interconnected by a lose collagen network (FIG. 2C). The top 
view of the gels showed a dense collagen network with randomly 
orientated collagen fibres (FIG. 2D).  
Defined compression improves biological stability of collagen gels  
A major drawback of uncompressed collagen gels is their tendency to 
lose volume when seeded with dermal fibroblasts (26). Volume loss can 
be caused by gel self-compression, contraction or collagen degradation, 
induced by fibroblasts during the process of cell-mediated ECM modulation 
(17, 26-28). 
To assess a time course of volume loss, we measured the gel’s wet 
weight as weight is proportional to volume (assuming constant mass 
density). Both, compressed and uncompressed gels, seeded with 5x104 
human primary dermal fibroblasts, were cultured under submersed 
conditions, and weighted during a time course of 21 days. Uncompressed 
gels (2 ml) lost more than 60% of their original weight during the 21 day 
cultivation period whereas 5 ml gels compressed to 0.5 mm kept their 
original weight almost constant during the same time (FIG. 3). Of note, 
pronounced wet mass loss was typically accompanied by irregular surface 
area reduction (contraction, data not shown), therefore our results are in 
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line with the already reported reduction of gel surface area loss after 
plastic compression (29). 
Plastic compression of square hydrogels (7 x 7 cm) 
To generate dermo-epidermal skin substitutes in a clinically relevant 
size, we developed a gel casting and compression device and established 
culture conditions that allowed the growth of larger, 7 x 7 cm dermo-
epidermal skin substitutes. 
The casting/compression device was developed utilizing computer 
aided design software (CAD), then cut from polytetrafluoroethylene (PTFE) 
using a computerized numerical control (CNC) drilling machine. As 
depicted in FIG. 4A and B, the new device consisted of four major parts: 
I) a perforated base plate onto which a filter paper and a porous PET track 
etched membrane were placed; II) a casting frame that was clipped and 
sealed to the base plate; III) a compression stamp that fitted into the 
casting frame and was vertically guided by 4 steel bars; IV) adjustable 
weights to be placed onto the stamp to define the compression force. All 
parts can easily be disassembled for cleaning and sterilising. Using distinct 
stamp lengths, it was possible to exactly determine the final thickness of 
the compressed gel.  
Square hydrogel (7 x 7 cm) were cast into the device and 
compressed to 0.6 mm, 2 h after gelation. Importantly, the gel could be 
poured, gelled, and compressed without the need to dislocate the 
mechanically weak uncompressed gel. After compression, the gels 
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obtained strong mechanical stability, so that lifting with forceps and 
transfer into culture dishes was easily possible (FIG. 4C). 
Generation of dermo-epidermal skin substitutes using defined 
collagen gel compression 
Fibroblast-containing, compressed hydrogels did not settle down to 
the cell culture dish. Therefore floating cultivation without any mechanical 
support was possible. 
Fluorescein diacetate (FdA) vital staining confirmed fibroblast survival 
in compressed gels (data not shown). Beta-actin staining using 
Phycoerythrin conjugated Phalloidin, followed by confocal microscopy, 
showed the formation of three dimensional networks of fibroblasts, 
already 5 days after gel compression (FIG. 5A). This fibroblast network 
was stable for at least 3 weeks (data not shown).  
Seven days after compression, keratinocytes were seeded at high 
density onto one surface of these gels. Thereafter, the dermo-epidermal 
skin substitutes were cultured for additional seven days, freely floating in 
medium. At this stage, FdA staining confirmed that the entire upper 
surface of the gel was covered by a confluent keratinocyte layer (FIG. 5B 
and 5B’). Cultured compressed gel-based, dermo-epidermal substitutes 
did not deform or shrink during this 14 days incubation period. 
H&E staining revealed a continuous keratinocyte layer with limited 
stratification (2-3 layers - a stratum corneum could not yet be observed) 
at this time, as expected (FIG. 5C). Importantly, healthy fibroblasts were 
still detectable in the gels. Since square skin substitutes, 7x7cm in size, 
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can neither be cultured at the air-liquid interphase, nor transplanted onto 
immune incompetent rats, we cut round sample areas, 2.6 cm in diameter, 
from the 7 x 7 cm skin substitutes and processed them for subsequent in 
vitro and in vivo experiments. For in vitro stratification, these samples 
were cultured for additional 10 days in 6-well cell culture inserts at the 
air-liquid interphase. H&E staining revealed a multilayered cornified 
epidermis (FIG. 5D).  
 
In vivo studies 
For in vivo studies, samples were transplanted on full thickness 
wounds onto immuno-incompetent rats. Within 3 weeks after 
transplantation, the skin substitutes developed a homogenous skin-like 
appearance on the entire transplant area (FIG. 6A). H&E staining 
revealed a near normal skin morphology with a multilayered (stratified) 
cornified epidermis on top of a fibroblast containing dermal component 
(FIG. 6B).  
The quality of the transplanted skin substitutes was evaluated by 
immunofluorescence staining employing a set of established markers for 
skin homeostasis and biological function (15, 30-33). Keratin 15 (K15) is a 
marker for basal keratinocytes anchored to a functional basement 
membrane in young normal interfollicular skin and indincates skin 
homeostasis. The majority of basal keratinocytes expressed K15 while no 
suprabasal K15 expression was detectable 3 weeks after transplantation 
(FIG. 6C).  
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An additional strong indicator for epidermal homeostasis is the 
expression of keratin 19 (K19) occurring exclusively in basal keratinocytes 
(15). Three weeks after transplantation, K19 expression was restricted to 
a subset of basal, K15-positive keratinocytes, thus resembling the 
situation of a healthy young skin (FIG. 6C).  
Keratin 16 (K16), exclusively expressed in a wound healing situation 
(34-36) was no longer detected in the central part of the transplant (FIG. 
6D). Additionally, cell proliferation was restricted to basal keratinocytes, 
as shown by the cell proliferation marker Ki-67 (37) (FIG. 6D).  
A reliable indicator for keratinocyte differentiation is Keratin 1 (K1) 
expression throughout all suprabasal epidermal layers (FIG. 6E). Using 
laminin-332 antibodies, the onset of basal lamina deposition was detected 
(FIG. 6E). 
Melanocytes, that were co-isolated and cultured with the 
keratinocytes, survived on compressed gels and were evenly distributed in 
the basal epidermal layer, with extensions reaching into higher strata 
(FIG. 6F). As also shown in this figure, basal keratinocytes expressed the 
6 chain (FIG. 6F) of integrin 6ß4, the receptor for laminin-332. 
Immunostaining using a human specific fibroblast antibody (anti-
human CD90) showed the human origin of dermal fibroblasts in the 
transplant, whereas the underlying rat tissue was not stained (FIG. 6G). 
The thickness of the human-derived neodermis was 0.7 mm in non-fixed 
cryosections and therefore close to the original thickness of the 
transplanted gel (0.6 mm). Within this human dermis, rat vascular 
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structures could be detected using CD31 antibodies (FIG. 6H), indicating 
that the compressed hydrogels obviously allowed for efficient 
vacularization. In summary it can be said that all markers investigated 
showed expression patterns closely rembling young and functional skin. 
Scanning electron microscopy 
The immuno-fluorescence data mentioned above are supported by 
SEM analysis (FIG. 7). The stratum corneum covering the entire 
epidermal surface appeared very similar to the stratum corneum of 
normal human skin (sc in FIG. 7A). Freeze fracture SEM (FIG. 7B) 
revealed that the epidermis (ed) consisted of several layers of tightly 
packed keratinocytes, with prominent spherical nuclei (white arrowheads). 
In the demis (de) a dense network of collagen fibres was clearly visible. 
Within the dermis several blood vessels containing erythrocytes (white 
arrows) were detectable. Compared to hydrogels without seeded 
fibroblasts (FIG. 2C), cultured and transplanted engineered skin 
substitutes showed a largely altered ECM, exhibiting a denser and finer 
fibrillar network, thus indicating an active ECM modification by the cells. 
 
Discussion  
A crucial precondition for the production of complex (dermo-epidermal) 
skin substitutes is the extracellular matrix providing a substrate for all cell 
types involved. Collagen type I hydrogels are ideal in supporting the 3D 
distribution of fibroblasts within the gel, and the development of a 
continuous and evenly stratified epidermis on the gel (11, 15). However, 
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collagen gels are mechanically weak and cannot be safely handled in large 
sizes. We modified the originally described method of plastic compression 
(17) to generate mechanically resistant collagen hydrogels in clinically 
relevant sizes, to be used in combination with primary dermal and 
epidermal skin cells. Importantly, the resulting skin grafts can be securely 
and conveniently handled by the surgeon. Our modified hydrogel 
compression procedure is simple and reliable. It may be automated for 
serial production of full thickness skin grafts or for the generation of skin 
grafts used for high throughput testing. 
There are two important new features of the described compression 
procedure, which are: a) casting and compression of the hydrogel can be 
done within the same vessel, thus dislocation of the gel is not required. 
The small and round type of skin substitutes can even be cultured in the 
same vessel. and b) the final thickness of the gels generated by the 
method described here, can be exactly defined. We used hydrogels 
compressed to thicknesses of 500, 600 and 1000m, respectively. This is 
in contrast to the gel compression described by Brown et al which varied 
in thickness at around 60m (17).  
Of course, the effect of modified plastic compression on fibroblasts, 
keratinocytes and the potency to generate a dermo-epidermal skin graft in 
vitro and in vivo is of pivotal importance. Our data show that human 
primary dermal fibroblasts seeded into collagen hydrogels survive plastic 
compression, remain biologically active, exhibit a spindle-like morphology 
and form 3D networks. This is in accordance to previous publications, 
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reporting on the effects of plastic compression on, human dermal 
fibroblasts (17), murine dermal fibroblasts (29), human limbal fibroblasts 
(18) and human smooth muscle cells (38, 39). 
We found that the dermal compartment of the transplants was 
always well developed (700 m in thickness) and entirely intact, 3 weeks 
after transplantation. Keratinocyte proliferation and differentiation 
(stratification) is highly dependent on such a functional dermis, because 
an epidermis without the support of functional dermal fibroblasts would 
not survive (26, 40, 41). Apparently these fibroblasts are permanently 
producing a set of biologically active factors at physiological 
concentrations. The development of a naturally stratified and fully 
functional epidermis on compressed collagen gels is therefore a reliable 
indicator for the fruitful interaction between dermal fibroblast and 
epidermal keratinocytes. The basis for this profitable biological interaction 
is provided by the thickness, density, and consistency of the 
corresponding collagen hydrogel. 
 
Conclusions 
We show here that compressed collagen hydrogels are excellent matrices 
to enable successful in vitro and in vivo skin reconstitution. Importantly, 
no negative biological effects of compression are observed. The 
mechanical stability of compressed collagen gels is by far superior to those 
of uncompressed gels, while their admirable biological properties remain 
unaltered by the compression process. In essence it can be said that the 
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method of plastic compression of collagen type I hydrogels, and their 
organ-typic cellular population, make now the clinical application of this 
type of skin substitutes possible. 
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FIG. 1: Mechanical improvement of collagen gels by plastic 
compression. (A) Uncompressed collagen hydrogels are fragile and fold 
when manipulated with forceps. (B) Schematic view of round compression 
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stamp for 6-well cell culture inserts: I) Weight rings, II) compression 
stamp, III) 6-well cell culture membrane inserts. The gel (IV) is 
compressed in the cell culture insert in which it is prepared and remains in 
the insert for cultivation. (C) Compressed collagen hydrogels (5 ml gel 
compressed to 0.5 mm thickness) are significantly more stable which 
improves handling. Scale Bars: 1 cm (A and C) 
 
FIG. 2: Electron microscopy of compressed collagen gels. TEM showing striated collagen fibres in 
(A) uncompressed and (B) compressed gels. The fibre density is significantly higher in compressed gels. (C) 
SEM of a cross-section of a compressed collagen gel showing organisation of collagen in dense layers, 
interconnected by collagen fibres in lower density. (D) SEM top view of a compressed gel, showing regular 
collagen distribution within the dense layer. Scale bars: 0.5 µm (A and B), 10 µm (C), 2 µm (D). 
 
FIG. 3: Time course of gel wet weight loss: During a 21 day 
cultivation period, 5 ml collagen type I hydrogels seeded with fibroblasts 
and compressed to 0.5 mm thickness (open boxes) lost less than 15% of 
their original wet weight. Uncompressed gels (black rhombi) lost more 
than 60% under the same conditions. Error bars indicating standard 
deviation (n=3). 
 
FIG. 4: Compression of 7x7 cm collagen gels. (A) Engineering 
drawing of the square collagen gel compression chamber and (B) 
photograph of the assembled compression chamber with indications for 
the main components: I) perforated base plate, II) casting frame, III) 
compression stamp, IV) weights. (C) Large compressed gels are flexible 
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and elastic but strong enough to be easily handled with forceps without 
rupture. 
 
FIG. 5: In vitro cultivation of square compressed gels. (A) 
Confocal microscopy after phalloidin staining: fibroblasts (red) establish a 
three-dimensional network within the gel five days after compression. 
Nuclei are stained with D Hoechst 33342 (blue). (B) Fluorescein diacetate 
(FdA) staining 7 days after keratinocyte seeding (14 days after gel 
preparation) indicates coverage of the complete gel area with a confluent 
keratinocyte layer. Gel shrinkage is marginal after 14 days in culture; 
dotted square indicating initial size (7x7 cm). (b’) Higher magnification of 
the central area in (B) confirming a confluent keratinocyte layer. (C) H&E 
staining 7 days after keratinocyte seeding showing a continuous 
keratinocyte layer and vital fibroblasts in the gel (black arrows). (D) After 
additional 10 days cultivation at air-liquid interphase a multilayered 
cornified epidermis developed in vitro on top of the dermal component 
containing fibroblasts (H&E staining). Scale bars: 100 µm (A, B’), 1cm (B), 
50 µm (C, D).  
 
FIG. 6: Transplantation of 5.2 cm2 biopsies from 7 x 7 cm engineered skin substitutes. (A) 
Skin-like macroscopic appearance of transplants, 3 weeks after transplantation. (B) H&E staining revealing a 
stratified and cornified epidermis on top of the dermal compartment (gel with fibroblasts). (C) All basal 
keratinocytes show K15 expression (green); K19 expression (red) is restricted to a subpopulation of basal 
keratinocytes. (D) Keratinocyte proliferation is restricted to basal cells, shown by Ki-67 staining (red); K16 
expression (green) is not detectable in central parts of the transplant. The dashed line illustrates the interface 
between epidermis and dermis. (E) All suprabasal keratinocyte layers are positive for K1 (green); the basal 
lamina component laminin-332 (“lam332”, red) is continuously deposited. (F) Melanocytes (“Mel”, green) 
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survive on compressed gels and are exclusively located in the basal cell layer (as indicated by basal integrin 6 
staining (“6”, red)). (G) Human fibroblasts are detectable with human-specific CD90 antibody (green) in a 700 
m thick area above the rat tissue. The dotted line indicates the border between human and rat tissue. (H) 
CD31 positive vascular structures (red) originating from the rat wound bed reach into the dermal portion with 
CD90 positive human fibroblasts (green). Scale bars: 5 mm (A), 20 µm (B-F), 100 µm (G, H). 
Fig. 7: SEM of dermo-epidermal skin substitute three weeks after transplantation. (A) Top view 
of the transplant showing structures of the stratum corneum very similar to normal skin. (B) Section clearly 
showing a stratum corneum (sc), stratified epidermis (ed) with prominent keratinocytes with spherical nuclei 
(white arrowheads) and a dermis (de) with blood vessels containing erythrocytes (white arrows). Note the 
deposition of new extracellular matrix between the collagen fibres. This network resembles the collagen 
organisation in normal skin. Scale bars: 10 m (A) and 20 m (B). 
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 M
et
ho
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M
od
ifi
ed
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la
sti
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co
m
pr
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of
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ol
la
ge
n 
hy
dr
og
el
s p
ro
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de
s a
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al
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pp
lic
ab
le
 sk
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ut
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/te
n.T
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Th
is 
ar
tic
le
 h
as
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ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
